Disposition of 18750 shares by Chung Jane of Sutro Biopharma subject to Rule 16b-3
| EPRSQDelisted Stock | USD 0.0001 0.00 0.00% |
Slightly above 56% of EPIRUS Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading EPIRUS Biopharmaceuticals pink sheet suggests that many investors are alarmed at this time. EPIRUS Biopharmaceutica's investing sentiment overview a quick insight into current market opportunities from investing in EPIRUS Biopharmaceuticals. Many technical investors use EPIRUS Biopharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
EPIRUS |
Filed transaction by Sutro Biopharma Officer President And Coo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
EPIRUS Biopharmaceutica Fundamental Analysis
We analyze EPIRUS Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EPIRUS Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EPIRUS Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
EPIRUS Biopharmaceutica is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
EPIRUS Biopharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EPIRUS Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of EPIRUS Biopharmaceutica could also be used in its relative valuation, which is a method of valuing EPIRUS Biopharmaceutica by comparing valuation metrics with similar companies.
Peers
EPIRUS Biopharmaceutica Related Equities
| MOLN | Molecular Partners | 7.91 | ||||
| PHVS | Pharvaris | 6.48 | ||||
| GNTA | Genenta Science | 5.18 | ||||
| OPT | Opthea | 4.34 | ||||
| CNTA | Centessa Pharmaceuticals | 3.46 | ||||
| ERAS | Erasca | 3.00 | ||||
| HLVX | Hillevax | 2.39 | ||||
| NAMSW | NewAmsterdam Pharma | 0.14 | ||||
| MLYS | Mineralys Therapeutics, | 0.54 | ||||
| GLTO | Galecto | 0.72 | ||||
| STRO | Sutro Biopharma | 0.98 | ||||
| ANTX | AN2 Therapeutics | 2.17 | ||||
| EWTX | Edgewise Therapeutics | 4.37 | ||||
| PEPG | PepGen | 5.16 | ||||
| FBRX | Forte Biosciences | 8.10 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in EPIRUS Pink Sheet
If you are still planning to invest in EPIRUS Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EPIRUS Biopharmaceutica's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |